FDA Approved Medical Products for:

Pneumocystic carinii pneumonia

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Atovaquone
Trade Name
(Manufacturer Name)
Mepron®
(Glaxo Wellcome Inc.)
Indication
The FDA has approved this product to be used in this manner.
For the acute oral treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in patients who are intolerant to trimethoprim-sulfamethoxazole. Prevention of PCP in patients who are intolerant to trimethoprim-sulfamethoxazole.
More Information about this product Drug Information Portal

Generic Name Pentamidine isethionate
Trade Name
(Manufacturer Name)
Nebupent®
(APP Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Prevention of Pneumocystis carinii pneumonia in patients at high risk of developing this disease.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Trimetrexate glucuronate
Trade Name
(Manufacturer Name)
Neutrexin®
(Medimmune Oncology, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Concurrent leucovorin administration as an alternative therapy for the treatment of moderate to severe PCP in immunocompromised patients who are intolerant of, or are refractory to, trimethoprim sulfamethoxazole.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Pentamidine isethionate
Trade Name
(Manufacturer Name)
Pentam 300®
(APP Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of Pneumocystis carinii pneumonia.
More Information about this product Drug Information Portal
Medline Plus Health Information